Zydus Lifesciences (BOM:532321) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532321 Zydus Lifesciences Ltd BOM:532321
92 GF Score
Price ₹1,108.90
GF Value ₹1,158.89
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Zydus Lifesciences FFO?

FFO (Funds from operations) only applies to REITs.

BOM:532321
92GF Score
Zydus Lifesciences Ltd BOM:532321
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zydus Lifesciences (BOM:532321) Overvalued in 2026?

Based on GuruFocus' analysis, Zydus Lifesciences stock appears to be undervalued. The current stock price of ₹1,108.90 is trading 4.3% below its estimated GF Value™ of ₹1,158.89. GuruFocus considers Zydus Lifesciences to be Fairly Valued.

Key valuation signals for BOM:532321:

  • FFO:
  • GF Value™: ₹1,158.89 vs. price of ₹1,108.90 (4.3% below fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the BOM:532321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zydus Lifesciences Business Description

Other Exchanges ZYDUSLIFE:India
Address Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. It is engaged in the research, development, production, marketing, and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API), human formulations, animal health and veterinary, and consumer health and wellness products. Its products are marketed under brands like Amlodac, Inditel, Pivasta, and others. The company's operating segments are: Pharmaceuticals, which derives key revenue, and Consumer products. Geographically, it generates maximum revenue from the United States, followed by India, and other countries.
92GF Score

Get the complete analysis for BOM:532321

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,108.90
Price
₹1,158.89
GF Value